These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 12787325)

  • 1. Alpha-synuclein-positive structures in association with diffuse neurofibrillary tangles with calcification.
    Hishikawa N; Hashizume Y; Ujihira N; Okada Y; Yoshida M; Sobue G
    Neuropathol Appl Neurobiol; 2003 Jun; 29(3):280-7. PubMed ID: 12787325
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NACP/alpha-synuclein immunoreactivity in diffuse neurofibrillary tangles with calcification (DNTC).
    Yokota O; Terada S; Ishizu H; Tsuchiya K; Kitamura Y; Ikeda K; Uéda K; Kuroda S
    Acta Neuropathol; 2002 Oct; 104(4):333-41. PubMed ID: 12200618
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Colocalization of tau and alpha-synuclein epitopes in Lewy bodies.
    Ishizawa T; Mattila P; Davies P; Wang D; Dickson DW
    J Neuropathol Exp Neurol; 2003 Apr; 62(4):389-97. PubMed ID: 12722831
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cellular co-localization of phosphorylated tau- and NACP/alpha-synuclein-epitopes in lewy bodies in sporadic Parkinson's disease and in dementia with Lewy bodies.
    Arima K; Hirai S; Sunohara N; Aoto K; Izumiyama Y; Uéda K; Ikeda K; Kawai M
    Brain Res; 1999 Oct; 843(1-2):53-61. PubMed ID: 10528110
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Active, phosphorylation-dependent mitogen-activated protein kinase (MAPK/ERK), stress-activated protein kinase/c-Jun N-terminal kinase (SAPK/JNK), and p38 kinase expression in Parkinson's disease and Dementia with Lewy bodies.
    Ferrer I; Blanco R; Carmona M; Puig B; Barrachina M; Gómez C; Ambrosio S
    J Neural Transm (Vienna); 2001; 108(12):1383-96. PubMed ID: 11810403
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alpha-synuclein-positive structures in cases with sporadic Alzheimer's disease: morphology and its relationship to tau aggregation.
    Arai Y; Yamazaki M; Mori O; Muramatsu H; Asano G; Katayama Y
    Brain Res; 2001 Jan; 888(2):287-296. PubMed ID: 11150486
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clusterin/apolipoprotein J is associated with cortical Lewy bodies: immunohistochemical study in cases with alpha-synucleinopathies.
    Sasaki K; Doh-ura K; Wakisaka Y; Iwaki T
    Acta Neuropathol; 2002 Sep; 104(3):225-30. PubMed ID: 12172907
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Co-localization of alpha-synuclein and phosphorylated tau in neuronal and glial cytoplasmic inclusions in a patient with multiple system atrophy of long duration.
    Piao YS; Hayashi S; Hasegawa M; Wakabayashi K; Yamada M; Yoshimoto M; Ishikawa A; Iwatsubo T; Takahashi H
    Acta Neuropathol; 2001 Mar; 101(3):285-93. PubMed ID: 11307630
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alpha-synuclein-immunoreactive cortical Lewy bodies are associated with cognitive impairment in Parkinson's disease.
    Mattila PM; Rinne JO; Helenius H; Dickson DW; Röyttä M
    Acta Neuropathol; 2000 Sep; 100(3):285-90. PubMed ID: 10965798
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Limbic neuropathology in idiopathic Parkinson's disease with concomitant dementia.
    Bertrand E; Lechowicz W; Szpak GM; Lewandowska E; Dymecki J; Wierzba-Bobrowicz T
    Folia Neuropathol; 2004; 42(3):141-50. PubMed ID: 15535032
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship in the formation process between neurofibrillary tangles and Lewy bodies in the hippocampus of dementia with Lewy bodies brains.
    Iseki E; Takayama N; Marui W; Uéda K; Kosaka K
    J Neurol Sci; 2002 Mar; 195(1):85-91. PubMed ID: 11867079
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Widespread expression of alpha-synuclein and tau immunoreactivity in Hallervorden-Spatz syndrome with protracted clinical course.
    Saito Y; Kawai M; Inoue K; Sasaki R; Arai H; Nanba E; Kuzuhara S; Ihara Y; Kanazawa I; Murayama S
    J Neurol Sci; 2000 Aug; 177(1):48-59. PubMed ID: 10967182
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lewy bodies contain altered alpha-synuclein in brains of many familial Alzheimer's disease patients with mutations in presenilin and amyloid precursor protein genes.
    Lippa CF; Fujiwara H; Mann DM; Giasson B; Baba M; Schmidt ML; Nee LE; O'Connell B; Pollen DA; St George-Hyslop P; Ghetti B; Nochlin D; Bird TD; Cairns NJ; Lee VM; Iwatsubo T; Trojanowski JQ
    Am J Pathol; 1998 Nov; 153(5):1365-70. PubMed ID: 9811326
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aggregation of alpha-synuclein/NACP in the neuronal and glial cells in diffuse Lewy body disease: a survey of six patients.
    Piao YS; Wakabayashi K; Hayashi S; Yoshimoto M; Takahashi H
    Clin Neuropathol; 2000; 19(4):163-9. PubMed ID: 10919347
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alpha-synuclein pathology in Parkinson's and Alzheimer's disease brain: incidence and topographic distribution--a pilot study.
    Jellinger KA
    Acta Neuropathol; 2003 Sep; 106(3):191-201. PubMed ID: 12845452
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tau pathology in diffuse neurofibrillary tangles with calcification (DNTC): biochemical and immunohistochemical investigation.
    Tanabe Y; Ishizu H; Ishiguro K; Itoh N; Terada S; Haraguchi T; Kawai K; Kuroda S
    Neuroreport; 2000 Aug; 11(11):2473-7. PubMed ID: 10943706
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tau pathology in the olfactory bulb correlates with Braak stage, Lewy body pathology and apolipoprotein epsilon4.
    Tsuboi Y; Wszolek ZK; Graff-Radford NR; Cookson N; Dickson DW
    Neuropathol Appl Neurobiol; 2003 Oct; 29(5):503-10. PubMed ID: 14507342
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glial involvement in diffuse Lewy body disease.
    Terada S; Ishizu H; Yokota O; Tsuchiya K; Nakashima H; Ishihara T; Fujita D; Uéda K; Ikeda K; Kuroda S
    Acta Neuropathol; 2003 Feb; 105(2):163-9. PubMed ID: 12536227
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dementia with Lewy bodies showing advanced Lewy pathology but minimal Alzheimer pathology--Lewy pathology causes neuronal loss inducing progressive dementia.
    Uchikado H; Iseki E; Tsuchiya K; Togo T; Katsuse O; Uéda K; Kato M; Kosaka K
    Clin Neuropathol; 2002; 21(6):269-77. PubMed ID: 12489676
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Widespread occurrence of argyrophilic glial inclusions in Parkinson's disease.
    Hishikawa N; Hashizume Y; Yoshida M; Sobue G
    Neuropathol Appl Neurobiol; 2001 Oct; 27(5):362-72. PubMed ID: 11679088
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.